MCF Advisors LLC grew its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 50.0% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 36 shares of the biopharmaceutical company’s stock after purchasing an additional 12 shares during the period. MCF Advisors LLC’s holdings in Regeneron Pharmaceuticals were worth $32,000 as […]
MCF Advisors LLC boosted its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 50.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 36 shares of the biopharmaceutical company’s stock after acquiring an additional 12 shares during the period. […]
Linden Thomas Advisory Services LLC increased its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 5.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,607 shares of the biopharmaceutical company’s stock after purchasing an additional 136 shares […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target raised by UBS Group from $1,090.00 to $1,099.00 in a report released on Wednesday, Benzinga reports. UBS Group currently has a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of a number of other reports. Royal Bank of Canada reaffirmed an […]
Tobam lowered its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 13.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,564 shares of the biopharmaceutical company’s stock after selling 730 shares during the period. Tobam’s holdings in Regeneron Pharmaceuticals […]